MIDAZOLAM, 1mg/ml, 5ml, amp
STD
DINJMIDA5A-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
07/11/2024, 20:37:29
Former
Code(s):
-X
1.3 - Preoperative medication and sedation for short-term procedures
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
5.1 - Antiseizure medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05CD08
Anatomical Therapeutic Chemical Classification according to WHOCC
Substance listed as Narcotic Drug or Psychotropic Substance, and as precursors. Other substances may be subject to restrictions according to national regulations. These substances require an import permit from the country of destination when ordering.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
MIDAZOLAM
Therapeutic Action
Short-acting hypnotic and sedative with anxiolytic, anticonvulsant and muscle relaxant effect.
Derivative of the benzodiazepine group
Indications
Premedication, perioperative sedation, co-induction of general anaesthesia, sedation in intensive care.
First-line treatment for seizures in children, administered by buccal/intranasal route when IV access with diazepam is not possible.
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
For bucal/intranasal administration in children, it is recommended to use a mucosal atomization device.
Distribution to be controlled: narcotics register or supervision of amounts in and out, and storage under lock and key. (Cf Introduction: Narcotic and psychotropic medicines under international control).
Storage
Below 25ºC - Protect from sunlight